These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20432520)

  • 1. The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials.
    Siddiqui F; Bae K; Langer CJ; Coyne JC; Gamerman V; Komaki R; Choy H; Curran WJ; Watkins-Bruner D; Movsas B
    J Thorac Oncol; 2010 May; 5(5):631-9. PubMed ID: 20432520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.
    Firat S; Byhardt RW; Gore E
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):357-64. PubMed ID: 12243808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of gender, partner status, and race on locoregional failure and overall survival in head and neck cancer patients in three radiation therapy oncology group trials.
    Dilling TJ; Bae K; Paulus R; Watkins-Bruner D; Garden AS; Forastiere A; Kian Ang K; Movsas B
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e101-9. PubMed ID: 21549515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marital status and non-small cell lung cancer survival: the Lung Cancer Database Project in Japan.
    Saito-Nakaya K; Nakaya N; Akechi T; Inagaki M; Asai M; Goto K; Nagai K; Nishiwaki Y; Tsugane S; Fukudo S; Uchitomi Y
    Psychooncology; 2008 Sep; 17(9):869-76. PubMed ID: 18033697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
    Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
    J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.
    Werner-Wasik M; Scott C; Cox JD; Sause WT; Byhardt RW; Asbell S; Russell A; Komaki R; Lee JS
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1475-82. PubMed ID: 11121651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marital status independently predicts non-small cell lung cancer survival: a propensity-adjusted SEER database analysis.
    Chen Z; Yin K; Zheng D; Gu J; Luo J; Wang S; Chen H
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):67-74. PubMed ID: 31786738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.
    Bradley JD; Ieumwananonthachai N; Purdy JA; Wasserman TH; Lockett MA; Graham MV; Perez CA
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):49-57. PubMed ID: 11777621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparate outcomes in nonsmall cell lung cancer by immigration status.
    Chau B; Ituarte PH; Shinde A; Li R; Vazquez J; Glaser S; Massarelli E; Salgia R; Erhunmwunsee L; Ashing K; Amini A
    Cancer Med; 2021 Apr; 10(8):2660-2667. PubMed ID: 33734614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older.
    Driessen E; Detillon D; Bootsma G; De Ruysscher D; Veen E; Aarts M; Janssen-Heijnen M
    J Geriatr Oncol; 2019 Jul; 10(4):547-554. PubMed ID: 30876833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
    Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
    Barquín M; Calvo V; García-García F; Nuñez B; Sánchez-Herrero E; Serna-Blasco R; Auglytė M; Carcereny E; Rodriguez-Abreu D; López Castro R; Guirado M; Camps C; Bosch-Barrera J; Massuti B; Ortega AL; Del Barco E; Gonzalez-Larriba JL; Aguiar D; García-Campelo R; Dómine M; Agraso S; Sala MA; Oramas J; Bernabé R; Blanco R; Parejo C; Cruz A; Menasalvas E; Royuela A; Romero A; Provencio M
    Cancer Epidemiol; 2020 Aug; 67():101737. PubMed ID: 32450544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
    Rades D; Setter C; Dahl O; Schild SE; Noack F
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials.
    Du KL; Bae K; Movsas B; Yan Y; Bryan C; Bruner DW
    Support Care Cancer; 2012 Jun; 20(6):1317-25. PubMed ID: 21720747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience.
    Machtay M; Seiferheld W; Komaki R; Cox JD; Sause WT; Byhardt RW
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):847-53. PubMed ID: 10386642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
    Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.
    Speirs CK; DeWees TA; Rehman S; Molotievschi A; Velez MA; Mullen D; Fergus S; Trovo M; Bradley JD; Robinson CG
    J Thorac Oncol; 2017 Feb; 12(2):293-301. PubMed ID: 27743888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.